S423T (p.Ser423Thr) variant of SMAD3 (SMAD family member 3)

S423T (p.Ser423Thr) in SMAD3 (SMAD family member 3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Aneurysm-osteoarthritis syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes published literature and structural context.

S423T (p.Ser423Thr) variant details